Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
2(17%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
2
17%
Ph not_applicable
9
75%
Ph early_phase_1
1
8%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
2(16.7%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
90.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (8.3%)
Phase 12 (16.7%)
N/A9 (75.0%)

Trials by Status

completed975%
recruiting217%
terminated18%

Recent Activity

2 active trials
Showing 5 of 12
completednot_applicable

The Glucose-Independent Effects of Exogenous Glucagon on Insulin Secretion and Cognitive Function in Healthy Subjects

NCT06685146
recruitingnot_applicable

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

NCT06602141
recruitingearly_phase_1

Differing Levels of Hypoglycemia

NCT02445781
completednot_applicable

Type 1 Diabetes and Depression: Role of Brain Glutamate

NCT05355285
completedphase_1

A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes

NCT01789593
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06685146Not Applicable

The Glucose-Independent Effects of Exogenous Glucagon on Insulin Secretion and Cognitive Function in Healthy Subjects

Completed
NCT06602141Not Applicable

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

Recruiting
NCT02445781Early Phase 1

Differing Levels of Hypoglycemia

Recruiting
NCT05355285Not Applicable

Type 1 Diabetes and Depression: Role of Brain Glutamate

Completed
NCT01789593Phase 1

A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes

Completed
NCT01780272Phase 1

A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 Diabetes

Completed
NCT00742521Not Applicable

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3

Completed
NCT00780195Not Applicable

Metabolic Adaptations to Diabetes in African Americans

Completed
NCT00608179Not Applicable

Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia

Completed
NCT00732862Not Applicable

Metabolic Adaptation to Diabetes

Completed
NCT01205750Not Applicable

Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics

Completed
NCT00280085Not Applicable

The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

Terminated

All 12 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
12